Rampart Bioscience Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Out of Business

Rampart Bioscience General Information

Description

Developer of gene medicines intended to provide guarded, long-lasting treatments for various diseases. The company's platform offers proprietary development and delivery platforms, which together create optimized therapeutics in a revocable, non-viral format, thereby assisting patients with genetically driven diseases by integrating capabilities from various key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 233 West Chestnut Avenue
  • Suite 240
  • Phoenix, AZ 85013
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 233 West Chestnut Avenue
  • Suite 240
  • Phoenix, AZ 85013
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rampart Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 09-Jan-2026 Completed Out of Business
2. Early Stage VC (Series A) 11-Sep-2023 Completed Generating Revenue
1. Seed Round 01-Jan-2022 $40M $40M Completed Generating Revenue
To view Rampart Bioscience’s complete valuation and funding history, request access »

Rampart Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
Seed-2 36,044,609 $0.001000 $0.91 $0.91 1x $0.91 27.35%
Seed 12,440,000 $0.001000 $1 $1 1x $1 9.44%
To view Rampart Bioscience’s complete cap table history, request access »

Rampart Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene medicines intended to provide guarded, long-lasting treatments for various diseases. The company's pla
Drug Discovery
Phoenix, AZ
30 As of 2025

Shanghai, China

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rampart Bioscience Competitors (111)

One of Rampart Bioscience’s 111 competitors is StemiRNA Therapeutics, a Venture Capital-Backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
StemiRNA Therapeutics Venture Capital-Backed Shanghai, China
etherna Formerly VC-backed Niel, Belgium
Editas Medicine Formerly VC-backed Cambridge, MA
Genevant Corporate Backed or Acquired Vancouver, Canada
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
You’re viewing 5 of 111 competitors. Get the full list »

Rampart Bioscience Patents

Rampart Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026089719-A1 Dna vectors having specialized secondary structures for use in treating hypophosphatasia Pending 24-Oct-2024
WO-2026090562-A1 Dna vectors having specialized secondary structures for use in treating hypophosphatasia Pending 24-Oct-2024
WO-2025090786-A1 Reduced immunogenic gene therapy protocols using circular, extended cruciform containing non-viral vectors Inactive 24-Oct-2023
WO-2025090786-A9 Reduced immunogenic gene therapy protocols using circular, extended cruciform containing non-viral vectors Inactive 24-Oct-2023
AU-2023308977-A1 Non-immunogenic circular, non-viral dna vectors Pending 19-Jul-2022 C12N15/85
To view Rampart Bioscience’s complete patent history, request access »

Rampart Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rampart Bioscience FAQs

  • When was Rampart Bioscience founded?

    Rampart Bioscience was founded in 2019.

  • Where is Rampart Bioscience headquartered?

    Rampart Bioscience is headquartered in Phoenix, AZ.

  • What is the size of Rampart Bioscience?

    Rampart Bioscience has 30 total employees.

  • What industry is Rampart Bioscience in?

    Rampart Bioscience’s primary industry is Drug Discovery.

  • Is Rampart Bioscience a private or public company?

    Rampart Bioscience is a Private company.

  • What is Rampart Bioscience’s current revenue?

    The current revenue for Rampart Bioscience is .

  • How much funding has Rampart Bioscience raised over time?

    Rampart Bioscience has raised $125M.

  • Who are Rampart Bioscience’s competitors?

    StemiRNA Therapeutics, etherna, Editas Medicine, Genevant, and CRISPR Therapeutics are some of the 111 competitors of Rampart Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process